Introduction: Surgical weight loss has been shown to effectively lead to improvements of obesity associated comorbid conditions. The goal of our study was to compare the timing of comorbidity resolution between laparoscopic roux-en-y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB).
Methods: All patients (n=476) undergoing LRYGB or LAGB at our institution over a 2 year period were prospectively entered in a bariatric database. , Percentage excess weight loss and comorbidity changes were recorded at 2 and 6 weeks and 3, 6, and 12 months postoperatively. Comorbidities evaluated included diabetes (DM), hypertension (HTN), reflux (GERD), and obstructive sleep apnea (OSA)and their changes were assessed by the operating surgeon at each follow-up visit on a 4 point scale (1= resolved, 2= improved, 3= unchanged, 4= worse). Chi-square was used to compare differences in % comorbidity resolution at each interval. P
Program Number: P098